Industries > Pharma > Indian Pharmaceutical Market Forecast 2016-2026

Indian Pharmaceutical Market Forecast 2016-2026

Future Prospects for Leading Companies in Generics, OTC, Originator Products and Biosimilars Propelled by Growth in Key Therapeutic Areas

PUBLISHED: 01 December 2015
PAGES: 194
PRODUCT CODE: PHA0079
SUBMARKET: Regional Markets

Clear
WOOCS 2.2.1
SKU: PHA0079 Categories: ,

What can be expected from the Indian Pharmaceutical market? Which areas are going to grow at the fastest rates? This Visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.
 
Our 194-page report provides 117 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across the whole of the Indian pharmaceutical market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis) and commercial developments.

See revenue forecasts for the leading submarkets and indications
How will submarkets perform to 2026? Our study forecasts revenues in the following Indian Pharmaceutical submarkets:
• Generic Drugs
• Over-The-Counter (OTC) Drugs
• Patented Drugs
• Biosimilars

Indian Pharmaceutical Market Forecast 2016-2026

See revenue forecasts for the leading therapeutic areas
How will leading therapeutic areas perform to 2026? Our study forecasts revenues in therapeutic areas including:
• Infectious disease drugs
• Cardiovascular disease drugs
• Gastro-intestinal drugs
• Respiratory disease
• Pain relief / analgesics
• Diabetes
• Vitamins / Minerals / Nutrients
• Dermatology
• Central Nervous System (CNS)
• Gynaecology

Leading companies and potential for market growth
Overall revenue for the Indian Pharmaceutical market will reach $36.18bn in 2020, our work forecasts. We predict strong revenue growth through to 2026. An ageing population, increasing access to healthcare and increasing incidence of chronic diseases, especially diabetes and cardiovascular disease, will drive sales to 2026.

Our work analyses the key companies in the market. See Visiongain’s analysis of leading companies, including these:
• Sun Pharmaceutical Industries Limited
• Abbott Healthcare Private Limited (Abbott India)
• Cipla Ltd.
• Cadila Healthcare Ltd.
• GlaxoSmithKline Pharmaceuticals Limited (GSK India)
• Pfizer Limited. India
• Lupin Pharmaceuticals, Inc.,

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Historic revenue, analysis and discussion of company performance over the past 10 years
• Analysis of major products currently on the market
• Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect Indian pharmaceutical industry?
Our new report discusses issues and events affecting the Indian pharmaceutical market. You will find discussions, including qualitative analyses:
• Highly diverse market needing strong knowledge of key therapeutic indications
• Changing regulatory landscape challenging new entrants and major market players alike
• Emerging drug types with the potential to reshape the market

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Indian Pharmaceutical Market Forecast 2015-2026 report helps you
In summary, our 194-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Indian Pharmaceutical market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for each major submarket – discover prospects for leading pharmaceutical products in the following areas: Infectious disease drugs, Cardiovascular disease drugs, Gastro-intestinal drugs, Respiratory disease , Pain relief / analgesics, Diabetes, Vitamins / Minerals / Nutrients, Dermatology, Central Nervous System (CNS), Gynaecology
• Revenue forecasts to 2026 for the leading drug types – generics, OTC products, patented drugs and biosimilars
• Assessment of leading companies – analysis of products, revenue, mergers & acquisitions, sales by region, therapeutic area and product type
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the indian pharmaceutical market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Indian Pharmaceutical Market Forecast 2016-2026


Download sample pages

Complete the form below to download your free sample pages for Indian Pharmaceutical Market Forecast 2016-2026


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

READ

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

READ

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Categories

Category